2019 Immunity Immunization 
The Guardian - Pharmaceutical Industry
DECEMBER 4, 2023
Under a court reorganization plan, Sackler family members who controlled the Oxycontin maker were granted immunity and did not have to declare personal bankruptcy in exchange for a $6bn settlement, paid out over 10 years, to a fund created to offset costs created by the opioid dependency crisis that has cost hundreds of thousands of lives.
NY Times
JULY 4, 2021
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 17, 2021
The Sacklers said earlier they would exit the settlement deal if they were not granted immunity, and the judge in the bankruptcy court that accepted the deal – Robert Drain – said he did not want to jeopardise what was on offer by seeking further changes.
pharmaphorum
SEPTEMBER 2, 2021
A US federal judge has approved a bankruptcy settlement for Purdue Pharma that grants the Sackler family that owned the business immunity from any further civil lawsuits accusing them of contributing to opioid epidemic – to the consternation of campaigners.
NY Times
JUNE 11, 2025
s Advisory Committee on Immunization Practices. s independent scientific body on immunization. With so much happening, it can be difficult to know what’s truly concerning and what changes are probably fine — or even worthwhile. The firing of the A.C.I.P. members: The ousting of all 17 members is a warning of what might be coming.
ALiEM - Pharm Pearls
OCTOBER 11, 2024
Immune thrombocytopenia (ITP) is an acquired autoimmune disorder caused by autoantibodies against platelet antigens. Case Discussion Take-Home Points Immune thrombocytopenia is an acquired isolated thrombocytopenia that can be a primary disorder or secondary to viral illness, autoimmune syndrome, or immunodeficiency disease.
NY Times
DECEMBER 8, 2021
The antibody drug, Evusheld, was found to be strongly effective in preventing Covid in a clinical trial that enrolled mostly those at high risk.
Expert insights. Personalized for you.
102 
Let's personalize your content